Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 Jul 2023

Jaspers Jaap P M, Taal Walter, van Norden Yvette, Zindler Jaap D, Swaak Annemarie T, Habraken Steven J M, Hoogeman Mischa S, Nout Remi, van den Bent Martin J, Méndèz Romero Alejandra

Abstract excerpt

OBJECTIVE: The interpretation of new enhancing lesions after radiotherapy for diffuse glioma remains a clinical challenge. We sought to characterize and classify new contrast enhancing lesions in a historical multicenter cohort of patients with IDH mutated grade 2 diffuse glioma treated with photon therapy. METHODS: We reviewed all follow-up MRI's of all patients treated with radiotherapy for histologically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Multicenter Studies as Topic

Share to Mutation

Source

Identifiers

PMID: 37084885
DOI: 10.1016/j.radonc.2023.109674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma.PMID 37084885Read ↗

Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.Semantic proximity Read ↗

Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma Patients.Semantic proximity Read ↗

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.Semantic proximity Read ↗

Assessment of Therapeutic Outcome and Role of Reirradiation in Patients With Radiation-induced GliomaSemantic proximity Read ↗

MRI and PET Alterations in Adult Skull-Base Tumors: A Narrative Review of Proton versus Photon RadiotherapySemantic proximity Read ↗

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.Semantic proximity Read ↗

Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Semantic proximity Read ↗

Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery.Semantic proximity Read ↗

Survival, late toxicity and ability to return to work after proton radiotherapy for low grade gliomasSemantic proximity Read ↗

Early progressive disease in IDH-mutant grade 2 and 3 astrocytoma without CDKN2A/B homozygous deletions may indicate radiation necrosisSemantic proximity Read ↗

Dual-energy Spectral CT Quantitative Parameters for the Differentiation of Glioma Recurrence from Treatment-Related Changes: A Preliminary StudySemantic proximity Read ↗

Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.